top of page
![DISRUPTLogo-MedHorizontal[1].png](https://static.wixstatic.com/media/1ad237_0694e719fff24e1b99901c9a23a001c1~mv2.png/v1/fill/w_130,h_50,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/DISRUPTLogo-MedHorizontal%5B1%5D.png)
Diversity & IncluSion in Research Underpinning Prevention & Therapy Trials
![DISRUPTLogo-MedHorizontal[1].png](https://static.wixstatic.com/media/1ad237_0694e719fff24e1b99901c9a23a001c1~mv2.png/v1/fill/w_500,h_200,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/DISRUPTLogo-MedHorizontal%5B1%5D.png)
Diversity & Inclusion in Scientific Research Underpinning Prevention & Therapy Trials
Media Coverage
March 23, 2021 Increasing Diversity in Clinical Trials the Focus of New Stand Up To Cancer Team
March 23, 2021 Mount Sinai to Lead a Team Awarded $6 million to Decrease Disparities in Cancer Clinical Trials
March 23, 2021 CCNY & SU2C Teammates Seek to Increase Diversity in Cancer Clinical Trials
March 23, 2021- Mary Beth Terry Co- Leads Stand- Up to Cancer Health Equity Research Team
Publications
July 21, 2021 Is it ‘cancer prevention’ or ‘risk reduction’? #Wordsmatter
A discussion of why the widespread use of the words ‘cancer prevention’ should be replaced with words ‘cancer risk reduction’, recognizing the confusion and potential harm to patients from inaccurate use of the words ‘cancer prevention’.
bottom of page